News
Bioiberica whises to inform its customers that its heparin sodium is fully compliant with the new requirements established by the Heparin Sodium USP monograph revision that is effective in USP 37 NF32, on May 1st, 2014.
During the 9th ISFFEI, held at Thailands capital on May 11-17, 2015, Bioibericas Plant Physiology Division presented the results of a new Cera Trap® trial.
Bioberica Farma has launched DUARTRON, the only glucosamine on the market sold in hard gelatine capsules, a dosage form preferred by patients because of its ease of use. Furthermore, Duartron® is funded by the Spanish National Health System. Osteoarthritis is a disease affecting a large percentage of the population. In Spain, for instance, is the third most common chronic disease.
Bioiberica again attended the annual congress hosted by New Ag International journal.
Bioiberica just opened a new production site of Heparin derivatives within the expansion plan of its Science portfolio.